Other Assets, Noncurrent in USD of Emmaus Life Sciences, Inc. from Q3 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Emmaus Life Sciences, Inc. quarterly Other Assets, Noncurrent history and change rate from Q3 2010 to Q3 2025.
  • Emmaus Life Sciences, Inc. Other Assets, Noncurrent for the quarter ending 30 Sep 2025 was $167K, a 46.5% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Change (%)

Emmaus Life Sciences, Inc. Quarterly Other Assets, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $167K -$145K -46.5% 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 $168K -$140K -45.5% 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $222K -$88K -28.4% 31 Mar 2025 10-Q 15 May 2025
Q4 2024 $222K -$74K -25% 31 Dec 2024 10-Q 14 Nov 2025
Q3 2024 $312K +$19K +6.49% 30 Sep 2024 10-Q 19 Nov 2024
Q2 2024 $308K +$32K +11.6% 30 Jun 2024 10-Q 10 Sep 2024
Q1 2024 $310K +$33K +11.9% 31 Mar 2024 10-Q 10 Sep 2024
Q4 2023 $296K +$33K +12.5% 31 Dec 2023 10-K 14 Apr 2025
Q3 2023 $293K +$34K +13.1% 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $276K +$15K +5.75% 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $277K -$20K -6.73% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $263K -$32K -10.8% 31 Dec 2022 10-K 03 Jul 2024
Q3 2022 $259K -$34K -11.6% 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $261K -$29K -10% 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 $297K +$4K +1.37% 31 Mar 2022 10-Q 13 May 2022
Q4 2021 $295K -$1K -0.34% 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 $293K 30 Sep 2021 10-Q 12 Nov 2021
Q2 2021 $290K 30 Jun 2021 10-Q 01 Sep 2021
Q1 2021 $293K 31 Mar 2021 10-Q 01 Sep 2021
Q4 2020 $296K +$11K +3.86% 31 Dec 2020 10-K 31 Mar 2022
Q4 2019 $285K -$121K -29.8% 31 Dec 2019 10-K/A 10 Aug 2021
Q3 2019 $427K +$400K +1476% 30 Sep 2019 10-K 25 Jan 2021
Q2 2019 $18.1M* +$18M 30 Jun 2019 10-Q 26 Aug 2021
Q1 2019 $29.6K -$5.4K -15.4% 31 Mar 2019 10-Q 13 May 2019
Q4 2018 $406K +$375K +1197% 31 Dec 2018 10-K 25 Jan 2021
Q3 2018 $27.1K +$2K +7.97% 30 Sep 2018 10-Q 14 Aug 2019
Q2 2018 $35.2K +$23.5K +201% 30 Jun 2018 10-Q 10 Aug 2018
Q1 2018 $35K +$23.3K +199% 31 Mar 2018 10-Q 14 May 2018
Q4 2017 $31.3K +$17.7K +130% 31 Dec 2017 10-Q 20 Feb 2018
Q3 2017 $25.1K +$11.5K +84.6% 30 Sep 2017 10-K 11 Dec 2018
Q2 2017 $11.7K -$1.9K -14% 30 Jun 2017 10-Q 14 Aug 2017
Q1 2017 $11.7K -$13.9K -54.3% 31 Mar 2017 10-Q 15 May 2017
Q4 2016 $13.6K -$3.1K -18.6% 31 Dec 2016 10-Q/A 30 Mar 2017
Q3 2016 $13.6K +$9.5K +232% 30 Sep 2016 10-K 29 Dec 2017
Q2 2016 $13.6K -$4.1K -23.2% 30 Jun 2016 10-Q 15 Aug 2016
Q1 2016 $25.6K +$7.3K +39.9% 31 Mar 2016 10-Q 16 May 2016
Q4 2015 $16.7K -$2.1K -11.2% 31 Dec 2015 10-Q 17 Feb 2016
Q3 2015 $4.1K -$15.2K -78.8% 30 Sep 2015 10-K 22 Dec 2016
Q2 2015 $17.7K -$2.2K -11.1% 30 Jun 2015 10-Q 14 Aug 2015
Q1 2015 $18.3K -$2.1K -10.3% 31 Mar 2015 10-Q 18 May 2015
Q4 2014 $18.8K -$2.2K -10.5% 31 Dec 2014 10-Q 13 Feb 2015
Q3 2014 $19.3K -$2.2K -10.2% 30 Sep 2014 10-K 05 Jan 2016
Q2 2014 $19.9K -$2.1K -9.55% 30 Jun 2014 10-Q 14 Aug 2014
Q1 2014 $20.4K -$2.1K -9.33% 31 Mar 2014 10-Q 15 May 2014
Q4 2013 $21K -$2K -8.7% 31 Dec 2013 10-Q 13 Feb 2014
Q3 2013 $21.5K -$2.1K -8.9% 30 Sep 2013 10-K 29 Dec 2014
Q2 2013 $22K -$7.9K -26.4% 30 Jun 2013 10-Q 14 Aug 2013
Q1 2013 $22.5K -$8K -26.2% 31 Mar 2013 10-Q 15 May 2013
Q4 2012 $23K -$8K -25.8% 31 Dec 2012 10-Q/A 22 Feb 2013
Q3 2012 $23.6K +$15K +174% 30 Sep 2012 10-K 23 Dec 2013
Q2 2012 $29.9K +$11.3K +60.8% 30 Jun 2012 10-Q/A 11 Sep 2012
Q1 2012 $30.5K 31 Mar 2012 10-Q 15 May 2012
Q4 2011 $31K 31 Dec 2011 10-Q 14 Feb 2012
Q3 2011 $8.6K -$10.1K -54% 30 Sep 2011 10-K 15 Jan 2013
Q2 2011 $18.6K 30 Jun 2011 10-Q/A 09 Sep 2011
Q3 2010 $18.7K 30 Sep 2010 10-K 22 Dec 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.